Tiziano Crimella

Title: Tiziano Crimella: Innovator in Time-Specific Pharmaceutical Formulations

Introduction

Tiziano Crimella is a notable inventor based in Milan, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the development of time-specific controlled release dosage formulations. With a total of 5 patents to his name, Crimella's work focuses on improving the treatment of early morning pathologies.

Latest Patents

Crimella's latest patents include innovative methods for treating early morning pathologies. One of his key inventions provides methods of treating these conditions using a time-specific controlled release dosage formulation. This formulation is administered prior to sleep, allowing for the delivery of a pharmaceutically active agent at the time of awakening. The formulation consists of a core that includes the active agent and a swellable polymeric coating layer that delays the release of the agent for a predetermined period. Another patent outlines a method for achieving time-specific delivery of a pharmaceutically active agent, utilizing a similar core and coating structure.

Career Highlights

Throughout his career, Tiziano Crimella has worked with prominent companies in the pharmaceutical industry. Notable among these are Poli Industria Chimica Spa and Boehringer Biochemica S.p.a. His experience in these organizations has contributed to his expertise in pharmaceutical formulations and innovations.

Collaborations

Crimella has collaborated with esteemed colleagues such as Cesare Busetti and Ennio Iaccheri. These partnerships have likely enhanced his research and development efforts in the pharmaceutical sector.

Conclusion

Tiziano Crimella stands out as an innovative inventor in the pharmaceutical field, particularly with his advancements in time-specific drug delivery systems. His contributions continue to influence the treatment of early morning pathologies, showcasing the importance of innovation in healthcare.